(Total Views: 395)
Posted On: 06/24/2020 9:11:04 AM
Post# of 36519
Hello Dr. xxxxx
I hope you, your family and friends, and all who you love & care for are well.
In response to your question.
We will be setting interactive items like you describe on our new web platform shortly. The ability for you to get news directly from the company.
For today, and for far better and real-time alerts, I would suggest going into google for "Google Alerts" also "SEC Filings" alerts.
Put in Generex Biotechnology Corp. & or GNBT for the best source of real-time information today, this is what's best today.
Again, we will be providing this trough on our web platform as soon as it is possible to do so.
Also, all corporate items are updated as they happen and added to our website for review www.generex.com
Including links to all filings on Edgar (On our Investor Tab then click the Edgar Icon).
Regards.
Todd
Todd Falls
Generex Biotechnology Corporation
Communication Director & Investor Relations Officer
USA Headquarters:
Generex Biotechnology, Inc.
10102 USA Today Way
Miramar, FL 33025
Direct Office:1-800-391-6755 - 222
phone: 416.364.2551 ext. 222
e-mail: tfalls@nugenerex.com
www.generex.com
I hope you, your family and friends, and all who you love & care for are well.
In response to your question.
We will be setting interactive items like you describe on our new web platform shortly. The ability for you to get news directly from the company.
For today, and for far better and real-time alerts, I would suggest going into google for "Google Alerts" also "SEC Filings" alerts.
Put in Generex Biotechnology Corp. & or GNBT for the best source of real-time information today, this is what's best today.
Again, we will be providing this trough on our web platform as soon as it is possible to do so.
Also, all corporate items are updated as they happen and added to our website for review www.generex.com
Including links to all filings on Edgar (On our Investor Tab then click the Edgar Icon).
Regards.
Todd
Todd Falls
Generex Biotechnology Corporation
Communication Director & Investor Relations Officer
USA Headquarters:
Generex Biotechnology, Inc.
10102 USA Today Way
Miramar, FL 33025
Direct Office:1-800-391-6755 - 222
phone: 416.364.2551 ext. 222
e-mail: tfalls@nugenerex.com
www.generex.com
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)